Ultrastructural analysis of ICP34.5- herpes simplex virus 1 replication in mouse brain cells in vivo

Journal of Virology

Volumn 84, Issue 21, 2010, Pages 10982-10990

  Mehta, Hina ^a   Muller, Jacqueline ^a   Markovitz, Nancy S ^a,b  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFECTED CELL PROTEIN 34.5; UNCLASSIFIED DRUG; VIRUS PROTEIN; GAMMA 34.5 PROTEIN, HUMAN HERPESVIRUS 1; ONCOLYTIC VIRUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL DAMAGE; CELL TYPE; CYTOLYSIS; EPENDYMA CELL; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; GENE DELETION; HERPES SIMPLEX VIRUS 1; IN VIVO STUDY; INFECTION RISK; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SURVIVAL TIME; TUMOR CELL; TUMOR VOLUME; VIRUS REPLICATION; ANIMAL; BRAIN; DEFECTIVE VIRUS; GENETICS; HERPES SIMPLEX; ONCOLYTIC VIROTHERAPY; PATHOGENICITY; PATHOLOGY; ULTRASTRUCTURE; VIROLOGY;

ANIMALS; BRAIN; DEFECTIVE VIRUSES; GENE DELETION; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; MICE; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; VIRAL PROTEINS; VIRUS REPLICATION;

ANIMALIA; HUMAN HERPESVIRUS 1;

EID: 77957939286     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00337-10     Document Type: Article

References (36)

1. Andreansky, S., L. Soroceanu, E. R. Flotte, J. Chou, J. M. Markert, G. Y. Gillespie, B. Roizman, and R. J. Whitley. 1997. Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors. Cancer Res. 57:1502-1509.
2. Brown, S. M., A. R. MacLean, J. D. Aitken, and J. Harland. 1994. ICP34.5 influences herpes simplex virus type 1 maturation and egress from infected cells in vitro. J. Gen. Virol. 75:3679-3686.
3. Campadelli-Fiume, G., and B. Roizman. 2006. The egress of herpesviruses from cells: the unanswered questions. J. Virol. 80:6716-6717; author's replies 6717-6719.
4. Chou, J., E. R. Kern, R. J. Whitley, and B. Roizman. 1990. Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science 250:1262-1266. (Pubitemid 120031840)
5. Cocchi, F., L. Menotti, P. Mirandola, M. Lopez, and G. Campadelli-Fiume. 1998. The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells. J. Virol. 72:9992-10002.
6. Dambach, M. J., J. Trecki, N. Martin, and N. S. Markovitz. 2006. Oncolytic viruses derived from the gamma34.5-deleted herpes simplex virus recombinant R3616 encode a truncated UL3 protein. Mol. Ther. 13:891-898.
7. Del Bigio, M. R. 1995. The ependyma: a protective barrier between brain and cerebrospinal fluid. Glia 14:1-13.
8. Ejercito, P. M., E. D. Kieff, and B. Roizman. 1968. Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J. Gen. Virol. 2:357-364.
9. Everson, R. G., M. Gromeier, and J. H. Sampson. 2007. Viruses in the treatment of malignant glioma. Expert Rev. Neurother. 7:321-324.
10. Flint, S. J., L. W. Enquist, R. M. Krug, V. R. Racaniello, and A. M. Skalka. 2000. Principles of virology: molecular biology, pathogenesis and control. ASM Press, Washington, DC.
11. Gleason, D., J. H. Fallon, M. Guerra, J. C. Liu, and P. J. Bryant. 2008. Ependymal stem cells divide asymmetrically and transfer progeny into the subventricular zone when activated by injury. Neuroscience 156:81-88.
12. Hauwel, M., E. Furon, C. Canova, M. Griffiths, J. Neal, and P. Gasque. 2005. Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, "protective" glial stem cells and stromal ependymal cells. Brain Res. Brain Res. Rev. 48:220-233.
13. Jacobson, J. G., D. A. Leib, D. J. Goldstein, C. L. Bogard, P. A. Schaffer, S. K. Weller, and D. M. Coen. 1989. A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells. Virology 173:276-283.
14. Jing, X., M. Cerveny, K. Yang, and B. He. 2004. Replication of herpes simplex virus 1 depends on the γ(1)34.5 functions that facilitate virus response to interferon and egress in the different stages of productive infection. J. Virol. 78:7653-7666.
15. Johansson, C. B., S. Momma, D. L. Clarke, M. Risling, U. Lendahl, and J. Frisen. 1999. Identification of a neural stem cell in the adult mammalian central nervous system. Cell 96:25-34.
16. Kesari, S., T. M. Lasner, K. R. Balsara, B. P. Randazzo, V. M. Lee, J. Q. Trojanowski, and N. W. Fraser. 1998. A neuroattenuated ICP34.5-deficient herpes simplex virus type 1 replicates in ependymal cells of the murine central nervous system. J. Gen. Virol. 79(Pt. 3):525-536.
17. Kramm, C. M., M. Chase, U. Herrlinger, A. Jacobs, P. A. Pechan, N. G. Rainov, M. Sena-Esteves, M. Aghi, F. H. Barnett, E. A. Chiocca, and X. O. Breakefield. 1997. Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy. Hum. Gene Ther. 8:2057-2068.
18. Leuzinger, H., U. Ziegler, E. M. Schraner, C. Fraefel, D. L. Glauser, I. Heid, M. Ackermann, M. Mueller, and P. Wild. 2005. Herpes simplex virus 1 envelopment follows two diverse pathways. J. Virol. 79:13047-13059.
19. MacLean, A. R., M. ul-Fareed, L. Robertson, J. Harland, and S. M. Brown. 1991. Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence. J. Gen. Virol. 72:631-639.
20. Marconi, P., R. Argnani, E. Berto, A. L. Epstein, and R. Manservigi. 2008. HSV as a vector in vaccine development and gene therapy. Hum. Vaccin. 4:91-105.
21. Markovitz, N. S., D. Baunoch, and B. Roizman. 1997. The range and distribution of murine central nervous system cells infected with the gamma(1)34.5- mutant of herpes simplex virus 1. J. Virol. 71:5560-5569.
22. L3 protein of herpes simplex virus 1 is translated predominantly from the second in-frame methionine codon and is subject to at least two posttranslational modifications. J. Virol. 73:8010-8018.
23. Mehta, H., R. Haobam, U. Rajamma, and K. P. Mohanakumar. 2005. Evidence for the involvement of central serotonergic mechanisms in cholinergic tremor induced by tacrine in Balb/c mice. Behav. Brain Res. 163:227-236.
24. Mettenleiter, T. C., and T. Minson. 2006. Egress of alphaherpesviruses. J. Virol. 80:1610-1611; author's reply, 1611-1612.
25. Mineta, T., S. D. Rabkin, T. Yazaki, W. D. Hunter, and R. L. Martuza. 1995. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat. Med. 1:938-943.
26. Orvedahl, A., D. Alexander, Z. Talloczy, Q. Sun, Y. Wei, W. Zhang, D. Burns, D. A. Leib, and B. Levine. 2007. HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe 1:23-35.
27. Post, L. E., S. Mackem, and B. Roizman. 1981. Regulation of alpha genes of herpes simplex virus: expression of chimeric genes produced by fusion of thymidine kinase with alpha gene promoters. Cell 24:555-565.
28. Post, L. E., and B. Roizman. 1981. A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth. Cell 25:227-232.
29. Roizman, B., D. M. Knipe, and R. J. Whitley. 2007. Herpes simplex viruses, p. 2501-2601. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, PA.
30. Roller, R. J. 2008. Nuclear egress of herpesviruses. Virol. Sin. 23:406-415.
31. Sato, O., F. Takei, and S. Yamada. 1994. Hydrocephalus: is impaired cerebrospinal fluid circulation only one problem involved? Childs Nerv. Syst. 10:151-155. (Pubitemid 24154553)
32. Shen, Y., and J. Nemunaitis. 2006. Herpes simplex virus 1 (HSV-1) for cancer treatment. Cancer Gene Ther. 13:975-992.
33. Stannard, L. M., S. Himmelhoch, and S. Wynchank. 1996. Intra-nuclear localization of two envelope proteins, gB and gD, of herpes simplex virus. Arch. Virol. 141:505-524.
34. Sundaresan, P., W. D. Hunter, R. L. Martuza, and S. D. Rabkin. 2000. Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in mice. J. Virol. 74:3832-3841.
35. Talloczy, Z., W. Jiang, H. W. Virgin III, D. A. Leib, D. Scheuner, R. J. Kaufman, E. L. Eskelinen, and B. Levine. 2002. Regulation of starvation- and virus-induced autophagy by the eIF2-alpha kinase signaling pathway. Proc. Natl. Acad. Sci. U. S. A. 99:190-195.
36. Whitley, R. J., E. R. Kern, S. Chatterjee, J. Chou, and B. Roizman. 1993. Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models. J. Clin. Invest. 91:2837-2843.